|
US79726A
(en)
*
|
|
1868-07-07 |
|
Hbney bfllard |
|
JPS5245474B2
(enExample)
|
1972-04-19 |
1977-11-16 |
|
|
|
JPS5417754B2
(enExample)
*
|
1972-12-15 |
1979-07-02 |
|
|
|
CA1022544A
(en)
|
1972-12-21 |
1977-12-13 |
Yukiyasu Murakami |
Process of preparing a heterocyclic acyl group-substituted cephalosporin derivative
|
|
JPS587637B2
(ja)
*
|
1973-12-27 |
1983-02-10 |
住友化学工業株式会社 |
シンキペニシリンノ セイホウ
|
|
AT328085B
(de)
|
1974-04-23 |
1976-03-10 |
Sumitomo Chemical Co |
Verfahren zur herstellung neuer penicilline
|
|
US4215123A
(en)
*
|
1979-05-07 |
1980-07-29 |
American Home Products Corporation |
Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
|
|
US4468394A
(en)
*
|
1981-04-02 |
1984-08-28 |
Eisai Co., Ltd. |
Cephalosporin compounds
|
|
US4404201A
(en)
*
|
1981-11-13 |
1983-09-13 |
Warner-Lambert Company |
Cephalosporins
|
|
US4374138A
(en)
*
|
1981-11-13 |
1983-02-15 |
Warner-Lambert Company |
Antibacterial amide compounds, compositions, and methods of use
|
|
US4382089A
(en)
*
|
1982-03-02 |
1983-05-03 |
Warner-Lambert Company |
Antibacterial amide compounds, compositions thereof and methods of using them
|
|
US4710473A
(en)
*
|
1983-08-10 |
1987-12-01 |
Amgen, Inc. |
DNA plasmids
|
|
US5037826A
(en)
*
|
1986-10-15 |
1991-08-06 |
Schering Corporation |
1-substituted naphthyridine and pyridopyrazine derivatives
|
|
SU1735288A1
(ru)
|
1990-03-05 |
1992-05-23 |
Харьковский государственный фармацевтический институт |
Способ получени N-R-замещенных амидов 4-гидроксихинолон-2 карбоновой -3-кислоты
|
|
JP2988739B2
(ja)
*
|
1990-04-16 |
1999-12-13 |
協和醗酵工業株式会社 |
１，８−ナフチリジン−２−オン誘導体
|
|
JPH0493592A
(ja)
|
1990-08-09 |
1992-03-26 |
Nissan Motor Co Ltd |
回転蓄熱式熱交換器
|
|
IL100917A0
(en)
|
1991-02-16 |
1992-11-15 |
Fisons Plc |
Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
|
|
US5155115A
(en)
|
1991-03-12 |
1992-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
Thienopyridine derivatives
|
|
DE4138820A1
(de)
*
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
|
|
AU668694B2
(en)
|
1991-12-19 |
1996-05-16 |
Sanofi-Synthelabo |
Saccharin derivative proteolytic enzyme inhibitors
|
|
DE4227747A1
(de)
*
|
1992-08-21 |
1994-02-24 |
Basf Ag |
Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
|
|
US5502035A
(en)
*
|
1993-08-06 |
1996-03-26 |
Tap Holdings Inc. |
N-terminus modified analogs of LHRH
|
|
NZ270267A
(en)
*
|
1993-12-30 |
1997-03-24 |
Hoechst Ag |
3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions
|
|
JPH07224040A
(ja)
|
1994-02-07 |
1995-08-22 |
Fujisawa Pharmaceut Co Ltd |
キノリン誘導体
|
|
IL135495A
(en)
*
|
1995-09-28 |
2002-12-01 |
Hoechst Ag |
Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
|
|
DE19746287A1
(de)
|
1997-10-20 |
1999-04-22 |
Hoechst Marion Roussel De Gmbh |
Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
CA2260499A1
(en)
|
1998-01-29 |
1999-07-29 |
Sumitomo Pharmaceuticals Company Limited |
Pharmaceutical compositions for the treatment of ischemic brain damage
|
|
US6133285A
(en)
*
|
1998-07-15 |
2000-10-17 |
Active Biotech Ab |
Quinoline derivatives
|
|
GB9911047D0
(en)
*
|
1999-05-12 |
1999-07-14 |
Isis Innovation |
Assay method and means
|
|
WO2001085732A1
(en)
|
2000-05-12 |
2001-11-15 |
Kyorin Pharmaceutical Co., Ltd. |
Pyridobenzodiazine derivatives and processes for the preparation thereof
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
WO2002076396A2
(en)
|
2001-03-23 |
2002-10-03 |
Smithkline Beecham Corporation |
Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
|
|
EP1487472B1
(en)
|
2001-12-06 |
2019-06-26 |
Fibrogen, Inc. |
Treatment of ischemic or hypoxic conditions using heterocyclic carboxamides
|
|
US7358249B2
(en)
|
2002-08-13 |
2008-04-15 |
Shionogi & Co., Ltd. |
Heterocyclic compounds having inhibitory activity against HIV integrase
|
|
AU2003286594A1
(en)
|
2002-10-21 |
2004-05-13 |
Irm Llc |
Quinolones with anti-hiv activity
|
|
US7618940B2
(en)
*
|
2002-12-06 |
2009-11-17 |
Fibrogen, Inc. |
Fat regulation
|
|
WO2004104000A1
(ja)
|
2003-05-23 |
2004-12-02 |
Japan Tobacco Inc. |
トリサイクリック縮合環化合物およびその医薬用途
|
|
WO2004103974A1
(ja)
|
2003-05-23 |
2004-12-02 |
Japan Tobacco Inc. |
置換２－オキソキノリン化合物およびその医薬用途
|
|
US20060251638A1
(en)
*
|
2003-06-06 |
2006-11-09 |
Volkmar Guenzler-Pukall |
Cytoprotection through the use of hif hydroxylase inhibitors
|
|
CN102718708A
(zh)
*
|
2003-06-06 |
2012-10-10 |
菲布罗根有限公司 |
含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途
|
|
US8614204B2
(en)
|
2003-06-06 |
2013-12-24 |
Fibrogen, Inc. |
Enhanced erythropoiesis and iron metabolism
|
|
JP4057972B2
(ja)
*
|
2003-07-25 |
2008-03-05 |
富士通株式会社 |
半導体装置の製造方法
|
|
EP1658074B1
(en)
|
2003-08-01 |
2012-11-07 |
Fibrogen, Inc. |
Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
|
|
CN1839133A
(zh)
|
2003-08-22 |
2006-09-27 |
阿文尼尔药品公司 |
作为巨噬细胞移动抑制因子的抑制剂的取代的二氮杂萘衍生物及其在治疗人类疾病中的应用
|
|
US7378414B2
(en)
|
2003-08-25 |
2008-05-27 |
Abbott Laboratories |
Anti-infective agents
|
|
AU2004289638B2
(en)
|
2003-11-04 |
2009-10-01 |
Merck Sharp & Dohme Corp. |
Substituted naphthyridinone derivatives
|
|
ES2433477T3
(es)
|
2004-02-11 |
2013-12-11 |
Glaxosmithkline Llc |
Inhibidores de integrasa de VIH
|
|
TW200613307A
(en)
|
2004-05-17 |
2006-05-01 |
Tibotec Pharm Ltd |
4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
|
|
EP1849465A4
(en)
|
2005-02-18 |
2008-12-24 |
Takeda Pharmaceutical |
AGENS TO CONTROL THE FUNCTION OF THE GPR34 RECEPTOR
|
|
JP4792048B2
(ja)
|
2005-03-02 |
2011-10-12 |
ファイブロゲン インコーポレイティッド |
チエノピリジン化合物およびその使用方法
|
|
AR055319A1
(es)
*
|
2005-03-17 |
2007-08-15 |
Wyeth Corp |
Derivados de isoquinoleina, composiciones farmaceuticas y usos
|
|
JP5390184B2
(ja)
*
|
2005-06-06 |
2014-01-15 |
ファイブローゲン、インコーポレーテッド |
貧血の改良された治療方法
|
|
CN101242817B
(zh)
*
|
2005-06-15 |
2016-08-31 |
菲布罗根公司 |
HIF1α调节剂在治疗癌症中的用途
|
|
WO2007038571A2
(en)
*
|
2005-09-26 |
2007-04-05 |
Smithkline Beecham Corporation |
Prolyl hydroxylase antagonists
|
|
CA2634168C
(en)
*
|
2005-12-09 |
2013-04-23 |
Amgen Inc. |
Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
|
|
WO2007097929A1
(en)
|
2006-02-16 |
2007-08-30 |
Fibrogen, Inc. |
Compounds and methods for treatment of stroke
|
|
US7625927B2
(en)
*
|
2006-02-27 |
2009-12-01 |
Alcon Research, Ltd. |
Method of treating glaucoma
|
|
TW200808793A
(en)
*
|
2006-03-07 |
2008-02-16 |
Smithkline Beecham Corp |
Prolyl hydroxylase inhibitors
|
|
WO2007136990A2
(en)
|
2006-05-16 |
2007-11-29 |
Smithkline Beecham Corporation |
Prolyl hydroxylase inhibitors
|
|
TWI394747B
(zh)
|
2006-06-23 |
2013-05-01 |
Smithkline Beecham Corp |
脯胺醯基羥化酶抑制劑
|
|
JP4876041B2
(ja)
|
2006-08-30 |
2012-02-15 |
株式会社リコー |
画像形成装置
|
|
US20090011051A1
(en)
|
2006-09-28 |
2009-01-08 |
Roth Mark B |
Methods, Compositions and Articles of Manufacture for HIF Modulating Compounds
|
|
WO2008076425A1
(en)
*
|
2006-12-18 |
2008-06-26 |
Amgen Inc. |
Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
|
|
US7635715B2
(en)
*
|
2006-12-18 |
2009-12-22 |
Amgen Inc. |
Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
|
|
TW200845994A
(en)
*
|
2007-01-12 |
2008-12-01 |
Smithkline Beecham Corp |
N-substituted glycine derivatives: prolyl hydroxylase inhibitors
|
|
ES2442847T3
(es)
*
|
2007-04-18 |
2014-02-13 |
Amgen, Inc |
Quinolonas y azaquinolonas que inhiben la prolil hidroxilasa
|
|
WO2008137084A2
(en)
*
|
2007-05-04 |
2008-11-13 |
Amgen Inc. |
Diazaquinolones that inhibit prolyl hydroxylase activity
|
|
ES2389063T3
(es)
*
|
2007-05-04 |
2012-10-22 |
Amgen, Inc |
Derivados de tienopiridina y tiazolopiridina que inhiben la actividad prolil hidroxilasa
|